CN101951964B - 成像方法 - Google Patents

成像方法 Download PDF

Info

Publication number
CN101951964B
CN101951964B CN200880117542.XA CN200880117542A CN101951964B CN 101951964 B CN101951964 B CN 101951964B CN 200880117542 A CN200880117542 A CN 200880117542A CN 101951964 B CN101951964 B CN 101951964B
Authority
CN
China
Prior art keywords
compound
formula
chemical compound
amino acid
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880117542.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101951964A (zh
Inventor
S·彻蒂比
B·牛顿
M·索尔贝肯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of CN101951964A publication Critical patent/CN101951964A/zh
Application granted granted Critical
Publication of CN101951964B publication Critical patent/CN101951964B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN200880117542.XA 2007-11-19 2008-11-19 成像方法 Expired - Fee Related CN101951964B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US98884007P 2007-11-19 2007-11-19
GB0722650.9 2007-11-19
US60/988840 2007-11-19
GB0722650A GB0722650D0 (en) 2007-11-19 2007-11-19 Novel imaging method
US60/988,840 2007-11-19
PCT/EP2008/065824 WO2009071444A2 (en) 2007-11-19 2008-11-19 Novel imaging method

Publications (2)

Publication Number Publication Date
CN101951964A CN101951964A (zh) 2011-01-19
CN101951964B true CN101951964B (zh) 2013-05-29

Family

ID=38896533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880117542.XA Expired - Fee Related CN101951964B (zh) 2007-11-19 2008-11-19 成像方法

Country Status (8)

Country Link
US (1) US8834843B2 (enExample)
EP (1) EP2219681A2 (enExample)
JP (1) JP5709522B2 (enExample)
CN (1) CN101951964B (enExample)
BR (1) BRPI0820430A2 (enExample)
GB (1) GB0722650D0 (enExample)
RU (1) RU2505316C2 (enExample)
WO (1) WO2009071444A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2571486C1 (ru) * 2014-11-05 2015-12-20 Общество с ограниченной ответственностью "ДИАМЕД" Способ визуализации воспалений
EP3967704A4 (en) * 2019-06-11 2022-08-31 FUJIFILM Corporation CYCLIC PEPTIDE, CELLULAR SCAFFOLDING MATERIAL, CELL SEPARATION MATERIAL AND CULTURE MEDIUM

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054904A2 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix
WO2007066115A2 (en) * 2005-12-08 2007-06-14 Ge Healthcare Limited Novel imaging agents for fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159310A0 (en) 2001-07-10 2004-06-01 Amersham Health As Peptide-based compounds
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents
DE602004014795D1 (de) * 2003-10-01 2008-08-14 Merck Patent Gmbh Alfavbeta3 und alfavbeta6 integrin antagonisten als antifibrotische mittel
WO2006073314A1 (en) 2005-01-06 2006-07-13 Ge Healthcare As Optical imaging
US20080206151A1 (en) 2005-04-25 2008-08-28 Alan Cuthbertson Liposomes
EP1996013A4 (en) * 2005-09-21 2010-03-10 Dask Technologies Llc METHODS AND COMPOSITIONS FOR FUNCTIONALITY OF ORGANS AND TISSUES
WO2007148074A1 (en) 2006-06-21 2007-12-27 Hammersmith Imanet Limited Chemical methods and apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054904A2 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix
WO2007066115A2 (en) * 2005-12-08 2007-06-14 Ge Healthcare Limited Novel imaging agents for fibrosis

Also Published As

Publication number Publication date
WO2009071444A2 (en) 2009-06-11
GB0722650D0 (en) 2007-12-27
WO2009071444A9 (en) 2009-10-01
JP2011506273A (ja) 2011-03-03
BRPI0820430A2 (pt) 2015-05-26
JP5709522B2 (ja) 2015-04-30
RU2010119187A (ru) 2011-12-27
RU2505316C2 (ru) 2014-01-27
CN101951964A (zh) 2011-01-19
US8834843B2 (en) 2014-09-16
EP2219681A2 (en) 2010-08-25
US20100316565A1 (en) 2010-12-16
WO2009071444A3 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
CN101454026B (zh) 成像剂
ES2844586T3 (es) Inhibidores del antígeno prostático específico de membrana (PSMA) etiquetados con 18F y su uso como agentes de obtención de imágenes para el cáncer de próstata
EP0746340B1 (en) Peptide-chelator conjugates
EP0733060B1 (en) Metal chelators
EA037778B1 (ru) Меченые ингибиторы простатического специфического мембранного антигена (псма), их применение в качестве агентов для визуализации и фармацевтических агентов для лечения рака предстательной железы
CZ20032564A3 (cs) Značené antagonisty receptoru makrofágového lapače pro zobrazování atherosklerosy a citlivých plaků
WO2012177701A2 (en) Compositions, methods of synthesis and use of carbohydrate targeted agents
BR112015006453B1 (pt) Antagonista de grpr radiomarcado e composição terapêutica que o compreende
CN101325978A (zh) 用于纤维化的新显像剂
CN112043839A (zh) 靶向转铁蛋白受体的放射性同位素标记多肽显像剂及其应用
Nock et al. Novel bifunctional DATA chelator for quick access to site-directed PET 68 Ga-radiotracers: preclinical proof-of-principle with [Tyr 3] octreotide
CN103547291B (zh) 锝标记的肽
CN101951964B (zh) 成像方法
US7122622B2 (en) Peptide compounds having improved binding affinity to somatostatin receptors
TWI671077B (zh) 六聚乳糖NOTA衍生物、六聚乳糖正子肝受體造影劑的Ga-68放射標誌方法及六聚乳糖正子肝受體造影劑
ES2276168T3 (es) Acidos (4s,8s)- y (4r,8r)-4-p-nitrobencil-8-metill-3,6,9-triaza-3n,6n,9n-tricarboximetil-1,11-undecanodioicos y sus derivados, procedimientos para su preparacion y su utilizacion para la preparacion de agentes farmaceuticos.
JP7091241B2 (ja) 固形ガンのための新規なキニンベースのセラノスティックプローブとその使用
JP2008509921A (ja) 内皮特異的な生体内伝達のターゲティング剤としての熱ショックタンパク質
EP4640240A1 (en) Peptide-based radiopharmaceuticals for non-invasive imaging of the functional liver reserve
KR101658206B1 (ko) 전립선암의 진단 및 치료를 위한 가스트린유리펩티드수용체 길항서열 기반의 신규한 봄베신 유도체 화합물
CN115996761A (zh) 用于诊断和/或监测纤维化的化合物
CN119613501A (zh) 靶向肿瘤整合素α5β1的PET示踪剂及其标记前体、制备方法和应用
KR20120027023A (ko) 섬유생성화의 ｐｅｔ 영상화
Hua Research Progress on Asialoglycoprotein Receptor-Targeted Radiopharmaceuticals Designed for Hepatic Nuclear Medicine Imaging

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130529

Termination date: 20161119

CF01 Termination of patent right due to non-payment of annual fee